File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Network pharmacology reveals potential functional components and underlying molecular mechanisms of Andrographis paniculata in esophageal cancer treatment

TitleNetwork pharmacology reveals potential functional components and underlying molecular mechanisms of Andrographis paniculata in esophageal cancer treatment
Authors
KeywordsAndrographis paniculata
esophageal cancer
moslosooflavone
network pharmacology
panicolin
Issue Date2022
Citation
Phytotherapy Research, 2022, v. 36, n. 4, p. 1748-1760 How to Cite?
AbstractAntitumor and antimetastatic effects of the medicinal herb Andrographis paniculata (AP) in esophageal cancer (EC) have been previously reported. In this study, we aimed to uncover the potential functional components and the underlying molecular mechanisms of AP in EC treatment using network pharmacology and experimental validation. Twenty-two potential active AP compounds against EC were revealed, including the antitumor/antiinflammatory compounds panicolin, moslosooflavone, and deoxyandrographiside. Epidermal growth factor receptor (EGFR), signal transducer and activator of transcription 3 (STAT3), RAC-alpha serine/threonine-protein kinase (AKT1), prostaglandin-endoperoxide synthase 2 (PTGS2), chemokine (C-X-C motif) ligand 8 (CXCL8), phosphatidylinositol 4,5-bisphosphate 3-kinase subunit alpha (PIK3CA), and toll-like receptor 4 (TLR4) were most highly ranked among the predicted targets of AP in EC treatment and may play important roles in the anti-EC effects of AP. KEGG pathway analysis revealed the enrichment of multiple cancer-related pathways and signaling pathways. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blotting validation showed that overnight treatment with 850.3 μg/ml of AP water extract significantly reduced the mRNA expressions of EGFR and AKT in human EC-109 cells. The presence of panicolin and moslosooflavone in the AP water extract samples were confirmed using LC-MS against reference standards. This study has comprehensively revealed for the first time the potential functional components of AP in EC and explored the underlying molecular mechanisms. Future studies should characterize the potential pharmacological properties of the other highly ranked yet understudied compounds in AP detected.
Persistent Identifierhttp://hdl.handle.net/10722/343361
ISSN
2023 Impact Factor: 6.1
2023 SCImago Journal Rankings: 1.277

 

DC FieldValueLanguage
dc.contributor.authorCheung, Man Kit-
dc.contributor.authorYue, Grace Gar Lee-
dc.contributor.authorGomes, Adele Joyce-
dc.contributor.authorWong, Eric Chun Wai-
dc.contributor.authorLee, Julia Kin Ming-
dc.contributor.authorKwok, Frankie Hin Fai-
dc.contributor.authorChiu, Philip Wai Yan-
dc.contributor.authorLau, Clara Bik San-
dc.date.accessioned2024-05-10T09:07:29Z-
dc.date.available2024-05-10T09:07:29Z-
dc.date.issued2022-
dc.identifier.citationPhytotherapy Research, 2022, v. 36, n. 4, p. 1748-1760-
dc.identifier.issn0951-418X-
dc.identifier.urihttp://hdl.handle.net/10722/343361-
dc.description.abstractAntitumor and antimetastatic effects of the medicinal herb Andrographis paniculata (AP) in esophageal cancer (EC) have been previously reported. In this study, we aimed to uncover the potential functional components and the underlying molecular mechanisms of AP in EC treatment using network pharmacology and experimental validation. Twenty-two potential active AP compounds against EC were revealed, including the antitumor/antiinflammatory compounds panicolin, moslosooflavone, and deoxyandrographiside. Epidermal growth factor receptor (EGFR), signal transducer and activator of transcription 3 (STAT3), RAC-alpha serine/threonine-protein kinase (AKT1), prostaglandin-endoperoxide synthase 2 (PTGS2), chemokine (C-X-C motif) ligand 8 (CXCL8), phosphatidylinositol 4,5-bisphosphate 3-kinase subunit alpha (PIK3CA), and toll-like receptor 4 (TLR4) were most highly ranked among the predicted targets of AP in EC treatment and may play important roles in the anti-EC effects of AP. KEGG pathway analysis revealed the enrichment of multiple cancer-related pathways and signaling pathways. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and western blotting validation showed that overnight treatment with 850.3 μg/ml of AP water extract significantly reduced the mRNA expressions of EGFR and AKT in human EC-109 cells. The presence of panicolin and moslosooflavone in the AP water extract samples were confirmed using LC-MS against reference standards. This study has comprehensively revealed for the first time the potential functional components of AP in EC and explored the underlying molecular mechanisms. Future studies should characterize the potential pharmacological properties of the other highly ranked yet understudied compounds in AP detected.-
dc.languageeng-
dc.relation.ispartofPhytotherapy Research-
dc.subjectAndrographis paniculata-
dc.subjectesophageal cancer-
dc.subjectmoslosooflavone-
dc.subjectnetwork pharmacology-
dc.subjectpanicolin-
dc.titleNetwork pharmacology reveals potential functional components and underlying molecular mechanisms of Andrographis paniculata in esophageal cancer treatment-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1002/ptr.7411-
dc.identifier.pmid35174914-
dc.identifier.scopuseid_2-s2.0-85124719945-
dc.identifier.volume36-
dc.identifier.issue4-
dc.identifier.spage1748-
dc.identifier.epage1760-
dc.identifier.eissn1099-1573-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats